Program News
News and stories about members of the UNC Lineberger Clinical Research Program
-
Targeted treatment for cancer is providing “wonderful tomorrows”
Personalized cancer care – and lots of positivity – are helping Mark Braswell, who was diagnosed with stage 4 non-small cell lung cancer.
-
UNC Lineberger continues its national leadership in breast cancer research
UNC Lineberger researchers are leading next-generation clinical breast cancer trials as part of a national project using cutting-edge technologies to track tumor changes in real time.
-
Researchers awarded $11.2M grant to close endometrial cancer survival gap
The National Cancer Institute has awarded a Cancer Health Disparities Specialized Program of Research Excellence (SPORE) in Endometrial Cancer grant to UNC Lineberger’s Victoria Bae-Jump, MD, PhD, and Hazel Nichols, PhD.
-
Cancer center relaunches Grand Rounds to connect clinicians and researchers across the health system
UNC Lineberger has relaunched its Cancer Grand Rounds lecture series to encourage dialogue across specialties, improve patient outcomes and promote collaborative research.
-
UNC Lineberger launches study to evaluate multi-cancer detection tests
UNC Lineberger is recruiting participants for the Vanguard Study, which is evaluating a new type of blood test that screens for several types of cancer. This is the first study of the Cancer Screening Research Network.
-
UNC Lineberger launches groundbreaking trial for rare, aggressive thyroid cancer
UNC Lineberger has launched a first-of-its-kind clinical trial aimed at improving outcomes in BRAF wildtype anaplastic thyroid cancer (ATC). Siddharth Sheth, DO, MPH, and Jeffrey Blumberg, MD, FACS, are leading the trial.
-
Faith, advocacy and determination shaped patient’s journey to survivorship
Kwame Kwofie, a citizen of Ghana, found himself in uncharted territory when he faced a head and neck cancer diagnosis thousands of miles away from home.
-
UNC Lineberger expands access to cancer clinical trials across North Carolina
UNC Lineberger’s J. Kaitlin Morrison, PhD, and Carrie Lee, MD, PhD, launched a study to investigate whether UNC Health can successfully conduct hybrid cancer clinical trials across the state.
-
Carey named a ‘Giant’ of breast cancer care
Lisa Carey, MD, ScM, FASCO, was honored by OncLive as one of its 2025 Giants of Cancer Care for her significant contributions advancing the treatment and study of breast cancer.
-
UNC Lineberger awarded up to $28M to develop an adaptive clinical trial for metastatic breast cancer
UNC Lineberger will lead the development of a next-generation clinical trial for metastatic breast cancer. The new trial design will adapt treatment plans in near real-time by analyzing changes in each patient’s cancer and matching it to the most promising therapy.
-
Novel drug combination is safe and benefits people with acute myeloid leukemia who have a specific genetic profile
Joshua Zeidner, MD, and colleagues report that a combination therapy that adds a recently approved drug to the current standard of care for newly diagnosed acute myeloid leukemia showed high rates of complete remission in an early-phase clinical trial.
-
UNC Lineberger faculty and trainees present research, receive honors at cancer research meeting
UNC Lineberger faculty and trainees presented research findings and participated in panel discussions at the American Society of Clinical Oncology’s annual meeting in Chicago.
-
UNC faculty and trainees to present at the world’s largest clinical cancer research meeting
UNC faculty and trainees will share their latest research findings and clinical insights during talks, poster presentations and panel discussions during the American Society of Clinical Oncology’s annual meeting in Chicago, taking place May 30 – June 3.
-
What are my treatment options for prostate cancer?
Urologic oncologist Matthew Milowsky, MD, FASCO, discusses treatment options if you’ve been diagnosed with prostate cancer.
-
UNC Lineberger and UNC faculty and trainees present findings at AACR annual meeting
Nearly 30 UNC Lineberger and UNC faculty and trainees will present findings and participate during the American Association for Cancer Research annual meeting in Chicago, April 25-30.